BridgeBio Oncology Therapeutics’s (BBOT) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting BridgeBio Oncology Therapeutics is a Buy.

BridgeBio Oncology Therapeutics’s (BBOT) 20-Day exponential moving average is 12.27, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.

BridgeBio Oncology Therapeutics’s (BBOT) 50-Day exponential moving average is 12.15, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.

Advanced Chart >

BridgeBio Oncology Therapeutics (BBOT) Pivot Points

Jan 16, 2026, 12:30 PM

Classic

9.25

10.20

10.86

11.81

12.47

13.42

14.08

Fibonacci

10.20

10.82

11.20

11.81

12.43

12.81

13.42

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

BridgeBio Oncology Therapeutics (BBOT) Moving Averages

Jan 16, 2026, 12:30 PM

MA5

12.54Sell

12.20Sell

MA10

12.25Sell

12.26Sell

MA20

12.19Sell

12.27Sell

MA50

12.36Sell

12.15Sell

MA100

11.67Buy

11.82Buy

MA200

11.18Buy

11.39Buy

BridgeBio Oncology Therapeutics’s (BBOT) 10-Day exponential moving average is 12.26, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.

BridgeBio Oncology Therapeutics’s (BBOT) 100-Day exponential moving average is 11.82, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Buy.

BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 50-day simple moving average is 12.36, creating a Sell signal.

BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 100-day simple moving average is 11.67, creating a Buy signal.

BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 200-day simple moving average is 11.18, creating a Buy signal.

BridgeBio Oncology Therapeutics (BBOT) Technical Indicators

Jan 16, 2026, 12:30 PM

RSI (14)

48.22

Neutral

STOCH (9,6)

38.49

Neutral

STOCHRSI (14)

38.49

Neutral

MACD (12,26)

<0.01

Buy

ADX (14)

20.07

Neutral

Williams %R

-62.32

Buy

CCI (14)

-66.50

Neutral

ATR (14)

1.13

Ultimate Oscillator

45.69

Neutral

ROC

0.92

Buy

BridgeBio Oncology Therapeutics’s (BBOT) Relative Strength Index (RSI) is 48.22, creating a Neutral signal.

BridgeBio Oncology Therapeutics’s (BBOT) Trend Strength Indicator (ADX) is 20.07, creating a Neutral signal.

BridgeBio Oncology Therapeutics’s (BBOT) Commodity Channel Index (CCI) is -66.50, creating a Neutral signal.

BridgeBio Oncology Therapeutics’s (BBOT) Price Rate of Change (ROC) is 0.92, creating a Buy signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is BBOT a Buy, Hold, or Sell?

Based on BBOT’s technical indicators, BBOT is a Hold.

What is BBOT’s RSI (14)?

BBOT’s RSI (14) is 48.22, which suggests BBOT is a Neutral.

What is BBOT’s MACD?

BBOT’s MACD is <0.01, which suggests BBOT is a Buy.

What is BBOT’s 5-day moving average?

BBOT’s 5-day moving average is 12.54, which suggests BBOT is a Sell.

What is BBOT’s 20-day moving average?

BBOT 20-day moving average is 12.19, which suggests BBOT is a Sell.

What is BBOT’s 50-day moving average?

BBOT’s 50-day moving average is 12.36, which suggests BBOT is a Sell.

What is BBOT’s 200-day moving average?

BBOT’s 200-day moving average is 11.18, which suggests BBOT is a Buy.

What is BBOT’s Williams % R (14)?

BBOT’s Williams % R (14) is -62.32, which suggests BBOT is a Buy.

What is BBOT’s CCI (14)?

BBOT’s CCI (14) is -66.50, which suggests BBOT is a Neutral.